On October 23, 2024 General Proximity reported the company has been selected as one of the 24 awardees of the highly competitive Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women’s Health (Press release, General Proximity, OCT 23, 2024, View Source [SID1234649816]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chosen from over 1,700 applicants representing 34 countries, this recognition underscores the transformative potential of our technology in addressing unmet needs in women’s health. This $3M award will support our team as we advance next-gen proximity therapeutics for high value undruggable targets in the women’s cancer space toward the clinic.

We are honored by ARPA-H’s support on this groundbreaking program and remain committed to advancing solutions that redefine possibilities in women’s healthcare.